Standard TMS is typically delivered once daily over a 6 to 7 week period. In contrast, Accelerated TMS (aTMS) utilizes Theta Burst protocols to administer multiple micro-sessions per day across just 5 consecutive days, dramatically speeding up symptom reduction and remission.
Spravato® is an FDA-approved prescription nasal spray indicated for adults with Treatment-Resistant Depression (TRD), defined as individuals who have not achieved adequate improvement after trying at least two different oral antidepressants.
Yes. Major insurers (including Aetna, Blue Cross Blue Shield, United Healthcare, Cigna, Medicare, and Optum) routinely cover Standard TMS and Spravato®. Our clinical team manages all prior authorizations and benefits verification on your behalf.
No anesthesia or sedation is required. Patients remain completely awake, comfortable, and alert throughout the 3 to 19-minute session. Immediately following the appointment, you can safely drive and return to work or daily activities.